“It's such a privilege to start a career in oncology in 2025, because in our lifetime we can expect a paradigm shift from a reactive to a proactive approach in cancer screening, surveillance, and management.” Dr. Suguna Raju and Dr. Luke Li Stony Brook Medicine #WorldCancerDay

A basket study evaluated the efficacy of zenocutuzumab, a bispecific antibody against HER2 and HER3, in patients with solid tumors harboring NRG1 fusions. Among 158 patients, 30% had a response (including 42% with pancreatic cancer). Full eNRGy study results:

🔵Our study on LDL and metastatic CRC has been published ✅High LDL > colonic primary ❓Although they are considered equal when metastatic, colon and rectal cancers have different biology 🚨In patients treated without curative intent High LDL > earlier progression ❓ChT,

Integrative Oncology: Incorporating Evidence-Based Approaches for Patients With GI Cancers | American Society of Clinical Oncology Educational Book ascopubs.org/doi/full/10.12…

Total neoadjuvant treatment, Non-operative management and Radiotherapy-free strategies: New approaches for the management of pMMR/MSS locally advanced rectal cancer. A comprehensive review and evidence-based algorithm ejcancer.com/article/S0959-…

ESMO Clinical Practice Guideline interim update on the treatment of locally advanced oesophageal and oesophagogastric junction adenocarcinoma and metastatic squamous-cell carcinoma esmoopen.com/article/S2059-…

Patients with a prothrombotic clinical course often associated with thrombocytopenia may have a monoclonal paraprotein, even at low levels, that activates platelets by binding to platelet factor 4. Read the Brief Report: nej.md/4gKmrUs

Inpatient Immunotherapy Outcomes Study: A Multicenter Retrospective Analysis. ascopubs.org/doi/10.1200/OP… ASCO Journal of Clinical Oncology JCO Oncology Practice #Immunotherapy #PallOnc #GeriOnc #SuppOnc Deborah Doroshow @ElizabethPrsic

🧬Two-stage molecular testing in pancreatic cancer ESMO - Eur. Oncology Gastrointestinal Oncology ✅It may be more feasible and cost-effective than upfront comprehensive profiling 👉doi.org/10.1016/j.esmo… OncoAlert #cancer #oncology #MedX

Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data - The Lancet Oncology thelancet.com/journals/lanon…

Full article: Long-term yogurt intake and colorectal cancer incidence subclassified by Bifidobacterium abundance in tumor tandfonline.com/doi/full/10.10…

Symptom monitoring with electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT cluster-randomized trial | Nature Medicine nature.com/articles/s4159…

Pilot Randomized Trial of an Educational Intervention About Immunotherapy for Patients With Advanced #Cancer and Their Caregivers. jnccn.org/view/journals/… Journal of the @NCCN Mass General Cancer Center MGH Palliative Care & Geriatric Medicine #PallOnc #Immunotherapy #SuppOnc Laura Petrillo 🗽

Monoclonal gammopathy of unknown significance is common, often discovered incidentally and indolent. This Review summarizes evidence on the diagnosis and management of monoclonal gammopathy of unknown significance to guide clinical decision-making. ja.ma/4k14gwi

Celebrating our incredible #HemOncFellows during Fellow Appreciation Month this February! Their intelligence, hard work, and dedication to our patients are truly inspiring, and it's a privilege to work alongside them every day. Stony Brook Hematology Oncology Fellowship Stony Brook Medicine #fellowappreciation

Clinicogenomic landscape of #PDAC identifies KRAS mutant dosage as prognostic of overall survival Nature Medicine doi.org/10.1038/s41591… 👉Very comprehensive analysis on the impact of KRAS 👉Key for understanding de novo and acquired resistance to RAS 💊 ESMO - Eur. Oncology

We are pleased to announce that Dr. Luke Li Stony Brook Medicine will be the Stony Brook Hematology Oncology Fellowship Chief Fellow for academic year 2025-2026 👏

Why get certified? Because excellence is achieved when knowledge meets dedication. Today, we celebrate the incredible commitment of our certified #nurses who go above and beyond to provide the best care to our patients! #CertifiedNursesDay #HealthcareHeroes

🎓 Huge congrats to our graduating Hematology-Oncology fellows — Alessandra, Andrea & Suguna! Your dedication to advancing cancer care is truly inspiring. Wishing you continued success in this exciting next chapter! 🩸🧬 #HemeOnc #fellowshipgraduation Stony Brook Hematology Oncology Fellowship

🧬 Oncotype DX RS from metastatic breast cancer sites is feasible. 📈 Higher RS, frequent PR loss, and poor match with primary tumors may impact treatment planning. #BreastCancer #Oncology #PrecisionMedicine link.springer.com/article/10.100…